PP
CVS icon

Pacifica Partners’s CVS Health CVS Stock Holding History

Pacifica Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-463
Closed -$37.1K – 463
2025
Q4 		$37.1K Sell
463
-71
-13% -$5.6K 0.02% 200
2025
Q3 		$41K Buy
534
+124
+30% +$8.5K 0.01% 215
2025
Q2 		$28.1K Hold
410
– – 0.01% 241
2025
Q1 		$27.7K Hold
410
– – 0.01% 236
2024
Q4 		$18.1K Hold
410
– – 0.01% 299
2024
Q3 		$25.8K Buy
410
+149
+57% +$8.69K 0.01% 270
2024
Q2 		$14.8K Sell
261
-36,829
-99% -$2.3M 0.01% 326
2024
Q1 		$2.93M Sell
37,090
-258
-0.7% -$19.7K 1.3% 27
2023
Q4 		$2.65M Buy
37,348
+162
+0.4% +$11.5K 1.31% 26
2023
Q3 		$2.59M Buy
37,186
+871
+2% +$61.7K 1.41% 24
2023
Q2 		$2.53M Buy
36,315
+16,550
+84% +$1.18M 1.43% 26
2023
Q1 		$1.53M Buy
19,765
+19,650
+17,087% +$1.65M 0.92% 38
2022
Q4 		$10.7K Hold
115
– – 0.01% 276
2022
Q3 		$11K Buy
+115
New +$11.4K 0.01% 284
2022
Q1 		– Sell
-35,015
Closed -$3.64M – 483
2021
Q4 		$3.64M Sell
35,015
-149
-0.4% -$13.8K 2.38% 10
2021
Q3 		$2.98M Buy
35,164
+4,690
+15% +$393K 2.17% 12
2021
Q2 		$2.48M Buy
30,474
+1,700
+6% +$139K 1.89% 14
2021
Q1 		$2.15M Buy
28,774
+27,785
+2,809% +$2.02M 1.77% 14
2020
Q4 		$67K Sell
989
-26,021
-96% -$1.69M 0.06% 112
2020
Q3 		$1.58M Buy
27,010
+2,360
+10% +$147K 1.72% 20
2020
Q2 		$1.59M Buy
24,650
+14,325
+139% +$902K 1.77% 15
2020
Q1 		$520K Buy
10,325
+10,205
+8,504% +$681K 0.65% 41
2019
Q4 		$9K Buy
+120
New +$8.43K 0.01% 242

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pacifica Partners's CVS Position: Q1 2026 in Review

Pacifica Partners sold out of CVS Health (CVS) in Q1 2026, closing a stake of 463 shares — an estimated $37.1K sold.

Pacifica Partners first reported a position in CVS in Q4 2019 and held it in 23 quarters. The position peaked at $3.64M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Pacifica Partners reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Pacifica Partners sold 463 CVS Health shares in Q1 2026, an estimated $37.1K.
  • Pacifica Partners first reported a position in CVS Health in Q4 2019 and held it in 23 quarters.
  • Pacifica Partners's CVS Health position peaked at $3.64M in Q4 2021.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Pacifica Partners's 13F filing for Q1 2026, filed 9 Apr 2026.